This is a StreetInsider.com Premium Only Page

(JAN) –

May 16, 2024 04:00 PM JanOne (JAN) Closes Acquisition of ALT 5 Sigma

May 16, 2024 04:00 PM JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain Fintech

May 13, 2024 07:30 AM JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider

May 10, 2024 04:10 PM JanOne (JAN) to Acquire ALT 5 Sigma Inc

May 10, 2024 04:10 PM JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider

May 6, 2024 04:59 PM Form 8-K JanOne Inc. For: May 06

May 6, 2024 04:58 PM Form 424B5 JanOne Inc.

May 3, 2024 04:12 PM Form 10-Q JanOne Inc. For: Mar 30

Apr 30, 2024 04:09 PM Form S-8 JanOne Inc.

Apr 26, 2024 06:07 AM Form EFFECT JanOne Inc.

Apr 22, 2024 04:22 PM Form 8-K JanOne Inc. For: Apr 16

Apr 18, 2024 10:56 AM JanOne (JAN) Files $100M Mixed Shelf

Apr 18, 2024 10:55 AM Form S-3 JanOne Inc.

Apr 8, 2024 04:22 PM Form 10-K JanOne Inc. For: Dec 30

Mar 29, 2024 11:42 AM Form NT 10-K JanOne Inc. For: Dec 30

Mar 15, 2024 09:02 AM Form 8-K JanOne Inc. For: Mar 13

Mar 15, 2024 09:01 AM JanOne (JAN) Regains Nasdaq Compliance

Mar 15, 2024 09:00 AM JanOne Regains Compliance with Nasdaq's Listing Requirements

Feb 28, 2024 04:29 PM Form 8-K JanOne Inc. For: Feb 23

Feb 9, 2024 12:37 PM Form 8-K/A JanOne Inc. For: Feb 08

Feb 8, 2024 04:07 PM Form 8-K JanOne Inc. For: Feb 08

Jan 12, 2024 04:29 PM Form 8-K JanOne Inc. For: Jan 12

Nov 14, 2023 08:58 PM Form 10-Q JanOne Inc. For: Sep 30

Oct 11, 2023 04:33 PM Form 8-K JanOne Inc. For: Oct 09

Sep 22, 2023 05:01 PM Form 8-K/A JanOne Inc. For: Aug 18

Sep 21, 2023 11:30 AM JanOne to Present at the Dawson James 8th Annual Investment Conference

Sep 21, 2023 09:35 AM Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference

Sep 15, 2023 04:33 PM Form 8-K JanOne Inc. For: Sep 11

Aug 31, 2023 01:30 PM JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference

Aug 29, 2023 01:30 PM JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain

Aug 28, 2023 05:20 PM Form DEF 14A JanOne Inc. For: Oct 09

Aug 25, 2023 02:30 PM JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting

Aug 24, 2023 04:31 PM Form SC 13G/A JanOne Inc. Filed by: BIGGER CAPITAL FUND L P

Aug 23, 2023 04:34 PM Form 8-K JanOne Inc. For: Aug 18

Aug 22, 2023 05:30 PM JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 22, 2023 12:54 PM Form 424B5 JanOne Inc.

Aug 21, 2023 05:53 AM JanOne (JAN) Announces 899K Share Offering at $0.88/sh

Aug 18, 2023 07:00 PM JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 18, 2023 12:42 PM JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting

Aug 16, 2023 03:56 PM Form PRE 14A JanOne Inc. For: Oct 06

Aug 15, 2023 04:39 PM Form 10-Q JanOne Inc. For: Jul 01

Jul 7, 2023 04:19 PM Form 8-K/A JanOne Inc. For: Jun 26

Jun 30, 2023 04:24 PM Form 8-K JanOne Inc. For: Jun 26

Jun 28, 2023 08:30 AM JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain

May 22, 2023 04:32 PM Form 10-Q JanOne Inc. For: Apr 01

May 11, 2023 04:31 PM Form NT 10-Q JanOne Inc. For: Apr 01

Apr 25, 2023 05:04 PM Form 10-Q/A JanOne Inc. For: Jul 02

Apr 25, 2023 05:03 PM Form 10-Q/A JanOne Inc. For: Oct 01

Apr 21, 2023 04:31 PM Form 8-K JanOne Inc. For: Apr 17

Apr 18, 2023 08:31 AM JanOne (JAN) Completes Pre-IND Meeting with FDA on Jan123